Narayana Hrudayalaya Ltd. 2021 AR2
The report outlines Narayana Hrudayalaya Limited's operational and financial performance for the fiscal year 2020-21, highlighting its response to the COVID-19 pandemic. The company dedicated a significant portion of its beds and resources to treating over 15,000 COVID-19 patients and conducted extensive vaccination drives. Despite severe disruptions to elective procedures and a 17.4% decline in consolidated revenues, the company expanded its oncology care services and introduced tele-ICU wearable monitoring devices. Additionally, the company continued its community outreach through programs like the Care Companion Program and the Udaan scholarship.
Company: Narayana Hrudayalaya Ltd.
Sector: Healthcare & social services
Country: India
Year: 2021
Type: AR2
Pages: 248
Narayana Hrudayalaya Ltd.
The report outlines Narayana Hrudayalaya Limited's operational and financial performance for the fiscal year 2020-21, highlighting its response to the COVID-19 pandemic. The company dedicated a significant portion of its beds and resources to treating over 15,000 COVID-19 patients and conducted extensive vaccination drives. Despite severe disruptions to elective procedures and a 17.4% decline in consolidated revenues, the company expanded its oncology care services and introduced tele-ICU wearable monitoring devices. Additionally, the company continued its community outreach through programs like the Care Companion Program and the Udaan scholarship.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Apr 1, 2020 - Mar 31, 2021
Fiscal Year
2021
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees